The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
Ironknut - probably a combination of the general malaise of UK small-cap shares, a change of CE and fears that the current strikes in the USA will effect sales in their entertainment division. However a well run company with good long-term prospects so I intend to hold and may even top-up if share price deteriorates much further.
20% fall today after large rise last week - above average number of shares traded and mostly sells. Just profit taking or perhaps a fund raising in the offing and as usual those in the know what this to be at the lowest price possible. £1 million cash left at 30/9 but expansion plans and appointments will soon eat this up so perhaps new high of 17p was the catalyst to raise more cash. We will see. Whatever the case I have great hopes for this company and will add if price continues to drift.
Good luck to all holders. CY
Topped up this morning following Chairman's buy and acquistion as I really think this company has reached a tipping point with numerous positive developments this year and hopefully more to come. However my buy is shown as a sell due to large spread quoted. Everything above 205 is a buy in my opinion but they are all shown as sells because they are below the midway point of the spread (202/210). Perhaps MMs trying to persuade the weak to sell by making it look everybody is selling when this is not the case.
Gla, CY
MMs up to their usual tricks in an effort to acquire stock. With a mid-price of 6.75p unable to buy any but was quoted 6.825 to sell 100k and a recent buy for 65k has gone through at 7.4p. Mid-price should be at least 7p. This share is only going one way especially if any contract news drops. MMs not getting any of mine!
Disappointed that while good news continues to be announced by the company the share price continues to decline and shows no sign of stopping. Can only conclude that this is due to the recent stake taken by Chinese based HTC (at a bargain price)and the increasing tension between UK and China on trade, Hong Kong issues etc. I remain invested as consider this to be an outstanding company with great prospects. However the Chinese involvement has lessened my enthusiasm, particularly given their propensity to ignore IP rights and just make the item themselves. I will continue to hold for now but am in the process of reviewing all my shares and their trade with China as I anticipate the current situation could deteriorate further. Let's hope not and VRE can continue to progress and prosper.
GL to all holders, CY
Pontil
Not aware of anything from EKF but given links to Mount Senai commercial opportunities possible than one could emerge in future. Possibility of one however at RENX re Verici dx Ltd - see recent RNS there.
Country Yokel
Pontil - Based on their annual report for 2019 (see RNS published 7 April) they have 2,677,981 shares in RENX currently valued at around £13.6m. This has proved a sound investment and their indication that it has good prospects has been proved correct. They also have cash of around £14m so are well placed both for acquisitions and returning cash to shareholders via dividends. I have holdings in both and consider both to be outstanding investments for the future.
GLA, Country Yokel
Not a blue day after all following a promising start to the day with an increasing number of sells going through. Not sure why but let us hope there is no bad news forthcoming at the general meeting tomorrow and it is just MMs playing their usual games. As far as I am aware the results for 2019 have yet to be announced and hope they will be announced shortly as the company only has until the end of the month to do so otherwise shares will be suspended. I am a holder here as I think the company has outstanding prospects but holding off buying any more until I see what transpires during the rest of the month.
GL all, Country Yokel
I have watched this company for a while and am thinking about belatedly taking a position. It appears to be a good company with outstanding prospects and in the right place at the right time. The one thing that is holding me back is my concerns over their cash position. In the January trading up date it stated that it had a cash balances of £1.29m which on current burn rate of £0.2 million per month would give it enough cash up until end of June. Unless this position has improved over recent months it would appear a rights issue or placing could be expected in the near future. Grateful for views on this possibility before I decide whether to take the plunge or not. Another possibility of course could be a takeover (or investment) by one of the big players which has been suggested on the these pages. Anyway grateful for any views people may have on this.
Kiwi - Thank you for your correct advice over the importance to diversify re Covid19 stocks which is something all investors should do generally. I can assure you within my healthcare/covid19 portfolio I am well diversified nearly all of which I held before the terrible virus appeared on the scene. Didn't want to make any reference to them previously in case I was considered to be ramping but can understand from my previous post why you thought I needed to consider diversifying.
stt1 - From reading your posts you seem to be very negative on this share - in which case it appears unlikely that you hold any shares so not sure why you are posting here, albeit everybody is entitled to their opinion. Perhaps you held them previously, got frustrated by the lack of progress, sold out, missed the recent rise and want the share price to go back down again. Anyway my belief is that covid19 will change the world in which we live and that combined with the recent link-up with TSTL will transform sales at BYO. TSTL are a very well run and astute company whose share price is now 10 times that when I first invested. If they see benefits and value from linking up with BYO who am I to argue. As I said previously if this works out I would not be surprised to see a takeover here. We will just have to agree to differ on our opinions as to merits of investing in BYO and time will tell who is right.
good luck to all BYO investors
Have a very long standing investment in TSTL so when I saw the link up with BYO and having researched them I have taken the plunge here. Need for both their products can only increase even after pandemic hopefully disappears given the possibility of a second wave, recurrence of the virus in the future and increased awareness of the dangers of such viruses.
Would not be surprised to see TSTL takeover BYO in time if recent tie up is successful given they have had a working relationship for a number of years. However they may have competition given recent stake building in BYO from the Far East. Whatever way this works out confident that this will be a good long term investment although price could fall back in the short term with profit taking from the large rise this year - if so I will be more than happy to add to my investment.
Stay safe.
Thanks for your views Pyglet - was beginning to think no one was interested in this share. Accept what you say about shares being thinly traded but given the volumes traded in the 2 days found it hard to comprehend these justified a fall of 25%. Perhaps it was partly due to MMs marking the price down and obtaining shares on the cheap in advance of the trading update which I had failed to notice was due. Trading update positive but all about increasing revenues and as you say no mention of profit estimates or cash balance both of which will no doubt be affected by expansion of sales team. Suspect share will not take off until there is evidence of growing sustainable profits but still a buy in the 50s in my view. In terms of cash position latest figure I can find is in the results for year 2018 which shows it as $0.9 million as at 31 Dec. Don't think they will contemplate issuing more shares at current price levels.
All the best, CY
Must be a real stock shortage if 24K traded (19k buys 5k sells) can move the price up over 11% albeit there could be trades not reported on here. You could buy this share for 20p in May and while there has been some director buying not enough to move it up this much. I wonder given recent takeovers in the sector if there is any stake building going on and if so what the take out price would be? Happy to hold and watch developments although may be tempted to add in the unlikely event price buying dropped back below 30.
What has happened to the share price here - down a quarter in 2 days to just over 50p 2 weeks after a director buy in the 70s and a bullish AGM update? Anyone got any ideas - rights issue/placing perhaps given cash balances below £1m? Anyway think this is a well run small company with great prospects and a likely future takeover candidate. While recent dramatic fall worrying still tempted to add to my holding although wary of the saying about catching a falling knife but might wait to see if it falls below 50p first which I didn't think I would see again.
and spindok - the couple of small tick ups recently resulting from a few buys going through are probably due to buying in anticipation of good interim results being announced - they were announced on 7 Sept last year so due in the next couple of weeks. Have held this share for some time and traded some occasionally and have high hopes for its future. Tempted to top up again now although recognise that company is investing for the future so profits likely to be subdued for time being at least. ATB Country Yokel
DEBS1 - I suspect the recent buying activity is in advance of the publication of the half-year results to 30 June - they were released on 31 August last year so expected any day now. Let's hope the buyers are right and they are good as news has been thin on the ground recently. Downside to the recent buying activity is that as there are few free float shares available to market makers so they widen the spread to deter more buyers - now 1p. However it has not as people prepared to pay 4p for a share with a mid-price of 3.5p. Don't think I would be prepared to buy with such a spread - I am hoping the buyers know something that convinces them it is worthwhile doing so. ATB Country Yokel
Market seemed disappointed with trading update - perhaps they were expecting the normal exceeding expectations as opposed to just in line with forecasts. Anyway I was more than happy that the company is managing to increase profits while making significant investments in entering overseas markets, particularly the USA, and digital healthcare. TSTL is highly rated and rightly so given their products and potential to grow much further. Have held for a long time and firmly believe if they crack the American market they may yet another British company to disappear overseas. Will add on any weakness/market correction. GLA
jazz_01 - results for 2017 being issued on Thurs 31 May. A first quarter trading update was provided in the RNS issued on 23 April but here's hoping for news of some more contract wins at the same time as results.
Modern Water - think you may have misunderstood implications for MGR re this profit warning. It is the unit and investment trusts run by MGR that have 11% stake in Accrol, not MGR plc. A reduction in the value of Accrol shares will therefore directly affect only the value and performance of these trusts and not the value of MGR shares. I think therefore waiting for a 10% pullback is wishful thinking unless the marker really takes a dive. Had these shares for some time and seen steady progress - hopefully more to come although would not be surprised to see them involved in a merger or being bought out at some stage.
Glad to see a bounce back today. Suspect fall earlier in week was due to profit taking and DESTINY PHARMA floating on market on Monday. Long term it could provide some competition to TSTL with both battling to enter the US market. Long term holder here (in since under 50p) and have traded/sold some on way up - will continue to keep my core holding. IMO if successful entry obtained to USA we will be taken out at some stage. GLA.